DLHL
ZBH icon

Donald L. Hagan LLC’s Zimmer Biomet ZBH Stock Holding History

Donald L. Hagan LLC’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-618
Closed -$64K – 314
2016
Q1 		$64K Buy
+618
New +$59.8K 0.06% 125
2015
Q4 		– Sell
-618
Closed -$56K – 309
2015
Q3 		$56K Buy
+618
New +$62K 0.05% 131

Other funds holding ZBH

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Donald L. Hagan LLC's ZBH Position: Q2 2016 in Review

Donald L. Hagan LLC sold out of Zimmer Biomet (ZBH) in Q2 2016, closing a stake of 618 shares — an estimated $64K sold.

Donald L. Hagan LLC first reported a position in ZBH in Q3 2015 and held it in 2 quarters. The position peaked at $64K in Q1 2016. 765 funds tracked by Wall St. Rank hold ZBH as of Q2 2016.

  • Donald L. Hagan LLC reported no remaining Zimmer Biomet position as of Q2 2016 after selling out during the quarter.
  • Donald L. Hagan LLC sold 618 Zimmer Biomet shares in Q2 2016, an estimated $64K.
  • Donald L. Hagan LLC first reported a position in Zimmer Biomet in Q3 2015 and held it in 2 quarters.
  • Donald L. Hagan LLC's Zimmer Biomet position peaked at $64K in Q1 2016.
  • 765 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2016.

Based on Donald L. Hagan LLC's 13F filing for Q2 2016, filed 21 Jul 2016.